Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
HEPI's failure to add board members with reputable backgrounds (a front desk manager at a hotel in AZ? Really?) and form a JV with Battelle is disappointing. I hope it sees .40 and I will gladly sell my shares at that point.
Better late than never. Dahl should have held this call last month.
Liquid-nice analogy. Millions of dollars of research has shown PAZ might lower cholesterol in your hamster. Maybe Petco is interested in an additive deal.
Amigo-No demand and I am not giving away the shares. I will hold until there is a bounce and sell if it appears HEPI is doing nothing but selling shares to meet G&A expenses. I am not as patient as those willing to hold for years as the stock slowly drops.
Amigo- Still holding my lottery tickets. Research to date as failed to bring about shareholder gains. HEPI has not communicated to investors what progress to date has been made. Also, no patents have been filed recently. Top scientists still seem to see something in PAZ. Unfortunately, management has not communicated progress in research, announced BOD addition, engaged in IR and outreach to new money, etc.
Amigo= Thanks for the link to Gerwick's interview. An update from Dahl on the science and revamped website would be first steps to reaching out to new money. I imagine current investors want to see results soon so as to monetize their holdings prior to EOY and potential spike in capital gains taxes.
Amigo: Did you sell and lock in your short term gains?
HEPI promised investors a redesigned website by "late spring." I'm not sure post-Memorial Day constitutes "late spring" by anyone's definition.
Appears HEPI might have waited too long to bring PAZ to the market. Increasing HDL might be irrelevant.
http://www.webmd.com/cholesterol-management/news/20120516/raising-hdl-levels-may-not-lower-heart-attack-risk
Nothing of substance in the 10Q, which isn't surprising. Hopefully HEPI will share actual news within the next couple of weeks before "late spring" passes.
Amigo: The tape indicates the R&D efforts have been disappointing. If progress is not made soon to monetize PAZ, further dilution will occur and the stock will fall back into the teens.
Liquid has a basis for concern. HEPI has a history of going silent when R&D efforts fail. And then its boosters state that since no PR was ever issued, we don't know that the R&D failed, we only know it has not succeeded or some other double talk.
I plan on exiting my position if no news prior to Memorial Day. Academics and non-profit scientists typically vacation in the summer and I would not expect much to take place between Memorial and Labor Days. We will see more dilution soon as Dahl and Battelle cost money and there does not appear to be a rev stream in the near future.
Remember the article in SeekingAlpha touting HEPI and Fact Corp? Take a look at Fact Corp's (FCTOA) performance since that article.
Bwonder- Based on Amigo's comment, no news until August. I was hoping something before end of May. Yes, results take time. But HEPI does not have the cash to continue without major progress to entice more investors into the stock.
Liquid- Bidders seem to be gone and the stock will likely drift lower. Only a concern if you need to sell. I'll give Dahl and co. until end of May before reevaluating my position.
Amigo- HEPI stated new website end of spring, which would be late May. Low volume indicates no immediate news. And Dr. Gerwick needs time to analyze the results.
I realize there will likely be no news until end of May. However, these weeks are dragging. People underestimate the difficulty of patience when it comes to investing. Many preach it, but it's tough to practice. No filings (SEC or patent) have been posted. No internet "chatter." Management is doing a great job of keeping any developments (good or bad) under wraps. Bought more this week.
I believe HEPI stated late spring a new website would be released. I imagine publicity of research status would coincide with that event. Late spring to me would be around Memorial Day-approximately five more weeks. Certainly buyers are not afraid to pick up stock in the interim. I added to my position.
If nothing there, credible professionals would not be getting on board or increasing their involvement. I would like to see scientists and medical professionals put on the advisory board announced in 2010 to return and add their expertise.
I did say HEPI doesn't linger in the .30s. Was obviously hoping for a continued climb, but this trading activity is not all together surprising. It will probably hover around these levels and maybe drift lower if there's no news. Not a concern as long as volume is low.
HEPI doesn't linger in the 30s. It either shoots up or drops. Given the momentum, the former is more likely. Many events could trigger a surge-addition of a board member from food and bev or pharma industry, breakthrough in research at Battelle, JV with Battelle or food and bev or pharma company. I'd like to see a series of these developments within the next month. "Greed, for lack of a better word, is good."
589k shares traded on a Friday and a nice gain. Looking forward to next week; I wouldn't be surprised if HEPI released an 8K and conference call announcement.
Liquid: not saying there is no risk. I prefer the risk/reward ratio right now. Volume during the run ups is picking up and the last couple of dips volume has been lower aside from that 600k share dump, which appeared to be (in fact has proven to be) a desperation dump.
Amigo: I also see no online chatter or "pumping." Surely the stock must now be appearing on radars as it hits .30. The increased volume is promising and will only pick up with the price once more follow the stock. And that's saying nothing about news. Short of declaring the testing to be an absolute failure, I do not see any positive news causing the stock to drop. Expectations seem pretty low. Easy to exceed them.
Agreed. Nice volume and price holding along with that almost .30 buy toward the end of the day. The last time I thought it would hit .30, the stock dropped below .20. I'll bite my tongue. News by FRI would be nice. Let's hope it has all been packaged nicely and will be delivered with a big red bow.
Amigo, It's hard to argue against taking a 60% gain. Not sure how to read the ask and volume. It seemed to pick up, but no shortage of shares available. It's a gamble and I think the odds favor positive news, albeit late.
Amigo: Looking forward to this week. You're right, volume is no where near the 2010 run up, but believe last week was the canary in the coal mine. Perhaps it was buying on the assumption news will be released in the timeline given during the conference call. Or news on the results was leaked. Regardless, there seems to be confidence in the stock.
Willy- You buying again?
It looks like a series of announcements were made within 4-6 weeks in 2010 before volume really took off. Hopefully the lack of news means management has been setting us up for a similar pattern. I can see testing news, board addition, deal, etc. Really like how they structured CEO compensation. Every incentive for him to meet benchmarks and sign deals bringing in rev since he gets a percentage. I hope he gets filthy rich.
Amigo- You holding or taking short term gains? This run up resembles 2010; heading for a $1.
The author did mention he would be releasing a more detailed analysis. Hopefully this coincides with a website update and more importantly major news.
Thought we would see news today since Thursday seems to be a popular PR release day. We'll see how it holds up tomorrow.
AmigoMike: and IMO ...... leaks have been plugged. We're down to brass tacks.
Really? LOL
Looks like I did notice something brewing yesterday. GLTA
Decent volume and no drop in PPS. News on its way?
Great Dateline episode tonight focusing on phony labs. Gives me faith in HEPI since they have always chosen reputable labs/academic institutions.
Let's hope the next two weeks bring good news.
Amigo: wouldn't you agree that there should be heavier volume if good news was anticipated as soon as next week? During the last run up in 2010, the stock rocked up for a month before news on the WSU press conference was announced.
The lawsuit gives me hope for HEPI since Ceptazyme believes PAZ is worth fighting over. And if HEPI was not confident in the Battelle testing, they would likely not have gotten out of the MLM business so soon since that's their only hope for revenue if the tests at Battelle fail.
Understandably there is not a lot of confidence in this company, which is why the stock tanks when there is any real sell volume- no buyers. Back in 2010 the stock rocketed on appointments to the "science advisory board" and news out of WSU. At the time, people were asking "why all the selling" before and during the big WSU news conference. Now we see that these sellers knew what they were doing selling at .90. Clearly nothing short term (or since it has been two years, can we now say long term?) came out of that WSU announcement. Those who continued to engage in "short term speculative buying" have continued to get burned.
The MLM deal resulted in no meaningful sales and now costly lawsuits. We're told results from Battelle will be out in "a few weeks." The market doesn't seem to agree. And if results are announced, I doubt we'll see real gains until revenue is being generated.
I'm still in the stock because HEP Investments and long time shareholders have continued to pour money into the company despite these shortcomings. Either they've been hoodwinked or have confidence HEPI has a solid opportunity to generate shareholder value. I'll roll the dice; and so far I could use a capital gains offset this year.
Liquid- Appreciate the compilation of PRs.